by | Oct 18, 2022 | Genin, Guy, Williams, Dillon, Zayed, Mohamed
— Technology Description
Prof. Mohamed Zayed and colleagues have developed an arteriovenous graft cuff with features designed to normalize the blood shear rate and decrease risk of thrombosis at the venous end anastomosis. This device could reduce the failure rate of these grafts, thereby improving …
by | Feb 1, 2021 | Baldelomar, Edwin, Bennett, Kevin
— Technology Description:
Researchers at Washington University in St. Louis have developed targeted, natural nanoparticle imaging agents that may be used to quantify kidney nephron endowment and diagnose renal disease with MRI or PET imaging.
Nephrons are the functional units of the kidney responsi…
by | Jul 9, 2020 | Gong, Yong-feng, Hou, Jianghui
— Disease indication: metabolic disorders including insulin resistance and diabetic nephropathy
Drug format: chemically modified synthetic microRNA (miRNA)
Drug class: first-in-class for metabolic disease
Research stage and Preliminary data:
Target: miR-29 mimics can increase the gene expressio…
by | Feb 3, 2020 | Chen, Ying, Kim, Yeawon
— Technology Description
Researchers in Prof. Ying “Maggie” Chen’s laboratory have identified three sensitive, urine-based biomarkers of kidney disease that could be used for non-invasive, early detection and clinical trials monitoring. In particular, these mechanistic biomarkers a…
by | Oct 22, 2019 | Crimmins, Dan, Gaut, Joseph, Ladenson, Jack, Laterza, Omar, Lockwood, Christina, Modur, Vijay
— Technology Description
A team of researchers at Washington University in St. Louis have developed patented antibodies designed to identify MIOX (myo-inositol oxygenase), a renal-specific biomarker that can be detected immediately following acute kidney injury (AKI). AKI can be caused by surgery, s…